Single chain Fv antibodies against neural cell adhesion molecule L1 trigger L1 functions in cultured neurons.
The neural cell adhesion molecule L1 plays important roles in cell adhesion, neuronal migration, neurite outgrowth, fasciculation and pathfinding, neuronal survival, and synaptic plasticity. Many of these functions have been identified and characterized by using antibodies. Because of the need for reproducible and functionally active antibodies, we have generated two single-chain variable fragment antibodies against mouse L1 from a human synthetic phage display library. The complementarity determining region 3 of the variable heavy chains of the two antibodies differed in length and sequence. Both antibodies recognized mouse, but not human L1, by enzyme-linked immunosorbent assay, Western blot, and immunofluorescence staining of cultured neurons. Epitope mapping showed reactivity with the fibronectin type III repeats 1-2 of mouse L1. The antibodies stimulated neurite outgrowth from cerebellar dorsal, root ganglion and motor neurons when offered in substrate-coated form in a dose-dependent manner with maximal effects at approximately 32 nM. Furthermore, substrate-coated antibodies enhanced survival of cerebellar neurons. Peptides comprising 8 and 11 amino acids derived from the complementarity determining region 3 of the variable heavy chains of the two single-chain variable fragment antibodies also promoted neurite outgrowth. The combined observations indicate that single-chain variable fragment antibodies against L1 and peptides derived from their binding domains can mimic some beneficial functions of homophilically binding L1 in vitro and may thus serve to trigger these functions in vivo.
Dong
Ling
L
Zentrum für Molekulare Neurobiologie, Universität Hamburg, Martinistrasse 52, D-20246, Hamburg, Germany.
Chen
Suzhen
S
Schachner
Melitta
M
D000595:Amino Acid Sequence / Q000235:genetics; D000818:Animals; D000831:Animals, Newborn; D000906:Antibodies / Q000276:immunology / Q000302:isolation & purification* / Q000494:pharmacology; D000918:Antibody Specificity / Q000235:genetics / Q000276:immunology; D001665:Binding Sites / Q000235:genetics / Q000276:immunology; D016466:CHO Cells; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D002470:Cell Survival / Q000187:drug effects / Q000276:immunology; D002490:Central Nervous System / Q000166:cytology / Q000187:drug effects / Q000254:growth & development*; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects / Q000254:growth & development; D006224:Cricetinae; D018604:Epitope Mapping; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009046:Motor Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D039842:Neural Cell Adhesion Molecule L1 / Q000819:agonists* / Q000276:immunology / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010446:Peptide Fragments / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology; D019151:Peptide Library; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology
D000906:Antibodies; D039842:Neural Cell Adhesion Molecule L1; D010446:Peptide Fragments; D019151:Peptide Library; D011993:Recombinant Fusion Proteins